These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Catecholamine metabolism, depressive illness, and drug response. Maas JW, Fawcett JA, Dekirmenjian H. Arch Gen Psychiatry; 1972 Mar 02; 26(3):252-62. PubMed ID: 4551050 [No Abstract] [Full Text] [Related]
3. Catecholamine metabolism in affective disorders. 3. MHPG and other catecholamine metabolites in patients treated with lithium carbonate. Greenspan K, Schildkraut JJ, Gordon EK, Baer L, Aronoff MS, Durell J. J Psychiatr Res; 1970 Feb 02; 7(3):171-83. PubMed ID: 5440858 [No Abstract] [Full Text] [Related]
4. Catecholamine metabolism in affective disorders. IV. Preliminary studies of norepinephrine metabolism in depressed patients treated with amitriptyline. Schildkraut JJ, Draskoczy PR, Gershon ES, Reich P, Grab EL. J Psychiatr Res; 1972 Sep 02; 9(3):173-85. PubMed ID: 5083173 [No Abstract] [Full Text] [Related]
5. MHPG excretion by patients with affective disorders. Maas JW, Dekirmenjian H, Fawcett JA. Int Pharmacopsychiatry; 1974 Sep 02; 9(1):14-26. PubMed ID: 4600126 [No Abstract] [Full Text] [Related]
6. Biochemical changes in psychotic depression. High norepinephrine levels in psychotic vs neurotic depression. Bunney WE, Davis JM, Weil-Malherbe H, Smith ER. Arch Gen Psychiatry; 1967 Apr 02; 16(4):448-60. PubMed ID: 6022709 [No Abstract] [Full Text] [Related]
7. Norepinephrine metabolites as biochemical criteria for classifying depressive disorders and predicting responses to treatment: preliminary findings. Schildkraut JJ. Am J Psychiatry; 1973 Jun 02; 130(6):695-9. PubMed ID: 4701961 [No Abstract] [Full Text] [Related]
8. Catecholamine metabolism in affective disorders. II. Norepinephrine, normetanephrine, epinephrine, metanephrine, and VMA excretion in hypomanic patients. Greenspan K, Schildkraut JJ, Gordon EK, Levy B, Durell J. Arch Gen Psychiatry; 1969 Dec 02; 21(6):710-6. PubMed ID: 4901154 [No Abstract] [Full Text] [Related]
9. The investigation of adrenergic metabolism with 7H3-norepinephrine in psychiatric disorders. II. Temporal changes in the distribution of urinary tritiated metabolites in affective disorders. Rosenblatt S, Chanley JD, Leighton WP. J Psychiatr Res; 1969 May 02; 6(4):321-33. PubMed ID: 4307103 [No Abstract] [Full Text] [Related]
10. Adrenal function and alcoholism. II. Catecholamines. Ogata M, Mendelson JH, Mello NK, Majchrowicz E. Psychosom Med; 1971 May 02; 33(2):159-80. PubMed ID: 5549660 [No Abstract] [Full Text] [Related]
11. Toward a biochemical classification of depressive disorders. X. Urinary catecholamines, their metabolites, and D-type scores in subgroups of depressive disorders. Schatzberg AF, Samson JA, Bloomingdale KL, Orsulak PJ, Gerson B, Kizuka PP, Cole JO, Schildkraut JJ. Arch Gen Psychiatry; 1989 Mar 02; 46(3):260-8. PubMed ID: 2783211 [Abstract] [Full Text] [Related]
12. Toward a biochemical classification of depressive disorders. II. Application of multivariate discriminant function analysis to data on urinary catecholamines and metabolites. Schildkraut JJ, Orsulak PJ, LaBrie RA, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA. Arch Gen Psychiatry; 1978 Dec 02; 35(12):1436-9. PubMed ID: 727879 [Abstract] [Full Text] [Related]
13. A psychopharmacological study of catecholamines in affective disorders. Messiha FS, Savage C, Turek I, Hanlon TE. J Nerv Ment Dis; 1974 May 02; 158(5):338-47. PubMed ID: 4823934 [No Abstract] [Full Text] [Related]
14. A psychoendocrine study of pregnancy and puerperium. Treadway CR, Kane FJ, Jarrahi-Zadeh A, Lipton MA. Am J Psychiatry; 1969 Apr 02; 125(10):1380-6. PubMed ID: 4388045 [No Abstract] [Full Text] [Related]
15. Toward a biochemical classification of depressive disorders. I. Differences in urinary excretion of MHPG and other catecholamine metabolites in clinically defined subtypes of depressions. Schildkraut JJ, Orsulak PJ, Schatzberg AF, Gudeman JE, Cole JO, Rohde WA, LaBrie RA. Arch Gen Psychiatry; 1978 Dec 02; 35(12):1427-33. PubMed ID: 727878 [Abstract] [Full Text] [Related]
16. Catecholamine measures for diagnosis and treatment of patients with depressive disorders. Schatzberg AF, Orsulak PJ, Rosenbaum AH, Kruger ER, Schildkraut JJ, Cole JO. J Clin Psychiatry; 1980 Dec 02; 41(12 Pt 2):35-9. PubMed ID: 7440524 [Abstract] [Full Text] [Related]
17. Excretion of catecholamine metabolites by children with familial dysautonomia. Gitlow SE, Bertani LM, Wilk E, Li BL, Dziedzic S. Pediatrics; 1970 Oct 02; 46(4):513-22. PubMed ID: 5503687 [No Abstract] [Full Text] [Related]
18. [Catecholamine metabolism in the tissue of malignant and benign tumors of the sympathetic nervous system]. Käser H, Türler K, Burri PH. Schweiz Med Wochenschr; 1971 Apr 03; 101(13):484-7. PubMed ID: 5558918 [No Abstract] [Full Text] [Related]
19. Psychoendocrine study of oral contraceptive agents. Kane FJ, Lipton MA, Krall AR, Obrist PA. Am J Psychiatry; 1970 Oct 03; 127(4):443-50. PubMed ID: 4394090 [No Abstract] [Full Text] [Related]
20. Diagnostic subgroups of affective disorders and their urinary excretion of catecholamine metabolities. Deleon-Jones F, Maas JW, Dekirmenjian H, Sanchez J. Am J Psychiatry; 1975 Nov 03; 132(11):1141-8. PubMed ID: 1166890 [Abstract] [Full Text] [Related] Page: [Next] [New Search]